Exploring the Impact of a Medical Device Recall on Individuals with Obstructive Sleep Apnea and Healthcare Providers: A Qualitative Study
Clicks: 4
ID: 321501
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
4 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #2 of 39 articles by views in SLEEP Advances
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Study Objectives To understand how the Philips PAP device recall affected patient experiences, clinical practice, and health system responses. Methods We conducted a qualitative descriptive study using semi-structured interviews with individuals with OSA, physicians, respiratory therapists and health system leaders from November 2022-August 2023. Emailed responses from Health Canada were also incorporated. Interviews explored participants’ experiences with the recall announcement and communication, their own responses and perceptions of actions taken by others, the overall impact of the recall and suggestions for improving future recall processes. Data were analyzed using an inductive thematic approach with iterative coding and team-based analysis. Results We interviewed 47 participants (16 individuals with OSA, 10 physicians, 17 public or private respiratory therapists, five health system leaders). Four domains emerged: recall communication, execution, lived experiences, and policy context. Across groups, participants described a fragmented and poorly coordinated recall process with unclear accountability. Participants reported confusion due to inadequate information from Philips. Responsibility for notifying patients and device tracing shifted largely to healthcare providers and vendors, while replacement processes were disorganized and frustrating. Individuals with OSA experienced emotional distress and decisional uncertainty regarding therapy continuation. Providers described moral distress due to limited ability to support patients adequately, and vendors reported logistical and financial strain. While regulatory authorities indicated that standard procedures were followed, participants perceived these to be discordant from the recall process, contributing to erosion of trust. Conclusions The Philips PAP device recall exposed gaps between regulatory frameworks and real-world implementation, with broad individual and system-level impacts. Future recalls should prioritize accountability, coordination, and patient-centered support.
| Reference Key |
openalex_W7169566578
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sachin R. Pendharkar, Kenneth Blades, Bashour Yazji, Najib Ayas, Robert L Owens, Marta Kamińska, Constance Mackenzie, Andrea S Gershon, Diana Ratycz, Vadym Lischenko, Mark Fenton, Kerry McBrien, Marcus Povitz, Tetyana Kendzerska |
| Journal | SLEEP Advances |
| Year | 2026 |
| DOI |
10.1093/sleepadvances/zpag077
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.